Nabriva Therapeutics Announces Positive Topline Results from Global, Phase 3 Clinical Trial Evaluating IV and Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 18, 2017 Category: Pharmaceuticals Source Type: clinical trials

Managing Bacterial Pneumonia in Children Without Antimicrobials
Condition:   Pneumonia Intervention:   Other: Multimodal Therapy Sponsor:   ARCIM Institute Academic Research in Complementary and Integrative Medicine Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2017 Category: Research Source Type: clinical trials